Stay updated with breaking news from Cell Lines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The quality of materials and reagents used in Cell and Gene Therapy (CGT) production processes plays avital role in determining both the product quality as well as therapeutic safety, and external contaminantsmust be strictly controlled.
Angle, a liquid biopsy company with circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, has launched its Portrait PD-L1 test for the evaluation of PD-L1 protein expression on CTCs.
The Belgian biotech company Galapagos will work with Landmark Bio to deliver CAR-T cell therapies to patients more quickly than with traditional manufacturing methods.
The global Cell Line Development Industry is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. According to the latest market insights, total cell line product sales are expected to reach US$ 3,124.4 million in 2023, and a staggering US$ 4,674.8...
This article explores how biopharma production processes and cell culture manufacturing can be leveraged for the cultivated meat industry.